The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis

NCT06393972 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Glucocorticoid Resistant ICIs-related Myocarditis

Interventions

DRUG: Tofacitinib 5 MG BID

Sponsor

Shanghai Zhongshan Hospital